Annexon, Inc. (ANNX)
NASDAQ·Healthcare·Biotechnology
$6.01
-1.56%
Mkt Cap $703.22M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $3.25M | — | — | -$0.32 | -$0.28 | +12.50% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.34 | -$0.37 | -8.82% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.36 | -$0.34 | +5.56% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.30 | -$0.37 | -23.33% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$0.28 | -$0.33 | -17.86% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.26 | -$0.25 | +3.85% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.23 | -$0.23 | +0.00% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.32 | -$0.21 | +34.38% | — | — |
| Q1 2024 Mar 26, 2024 | — | $4.87M | — | -$0.45 | -$0.36 | +20.00% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.50 | -$0.43 | +14.00% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$0.54 | -$0.47 | +12.96% | — | — |
| Q2 2023 May 8, 2023 | — | — | — | -$0.52 | -$0.52 | +0.00% | — | — |
| Q1 2023 Mar 6, 2023 | — | — | — | -$0.52 | -$0.48 | +7.69% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.87 | -$0.51 | +41.38% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.94 | -$0.96 | -2.13% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$1.00 | -$0.92 | +8.00% | — | — |
| Q1 2022 Mar 1, 2022 | — | — | — | -$0.90 | -$0.97 | -7.78% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$0.88 | -$0.93 | -5.68% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.68 | -$0.82 | -20.59% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$0.60 | -$0.68 | -13.33% | — | — |